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Background: Diffuse myocardial fibrosis / extracellular matrix expansion is a landmark feature of various cardiac diseases and is 
associated with an unfavorable prognosis. Recently, cardiac magnetic resonance (CMR) T1-mapping has been proposed for the 
quantification of extracellular matrix. Published series mainly used: 1. Modified Look-Locker Inversion recovery (MOLLI), allowing the 
calculation of extracellular volume (ECV), 2. Post-contrast multiple breath-hold T1 mapping. Although T1 mapping been advertised as the 
new “non-invasive myocardial biopsy”, validation data are sparse.
methods: 43 heart failure patients underwent CMR T1 mapping, including MOLLI and multiple breath-hold T1 mapping, on a 1.5-T scanner 
(Avanto, Siemens Medical Solutions, Erlangen, Germany) and left ventricular biopsy within 4 weeks. The population consisted of 26 
patients with heart failure and preserved ejection fraction (HFpEF), 4 with reduced ejection fraction (HFrEF), 9 with cardiac amyloidosis, 
and 4 with chronic primary mitral regurgitation (MR). Left ventricular biopsies were stained with modified Trichrome and extracellular matrix 
was quantified with TissueFAXS and dedicated imaging software.
results: Extracellular matrix by TissueFAXS was 33±16% of the region of interest, ECV as determined by MOLLI was 35.6±12%. The 
average post-contrast T1 time by the multiple breath-hold sequence was 396±46ms and native T1 times were 1009±73ms. Patients with 
amyloidosis showed significantly higher ECV (55±10%, p<0.001) and extracellular matrix (59±12%, p<0.001). The amount of extracellular 
matrix by TissueFAXS correlated significantly with MOLLI ECV (r=0.877, p<0.001), native T1 times (r=0.673, p<0.001) and with multiple 
breath-hold post-contrast T1 times (r=-0.665, p<0.001). After excluding patients with amyloidosis, only MOLLI ECV significantly correlated 
with histology (r=0.545, p=0.002).
conclusion:  In the present series, MOLLI ECV appears to be the most accurate method for the quantification of extracellular matrix 
expansion when validated against myocardial biopsies. Future studies are needed to determine the prognostic value of T1 mapping in a 
large prospective cohort.
